Last synced on 12 October 2025 at 8:21 pm

Caries Detection Product With Drug Or Biologic

Page Type
Product Code
Definition
Intended to aid in the detection of tooth decay by measuring increased visible light, fluorescence, or luminescence induced by caries-activated drug or biologic.
Physical State
This product is comprised of intraoral imaging system with applicator mechanism for dispensing the drug or biologic. The intraoral imaging system contains a camera and is used with compatible imaging software.
Technical Method
Product dispenses the drug or biologic onto accessible teeth in the patient’s mouth. The drug or biologic binds to caries-related constituents naturally occurring in the mouth, which induces the drug or biologic to give off increased visible light, fluorescence, or luminescence. Images of the detected visible light, fluorescence, or luminescence are used by the dental healthcare professional to see the carious lesions activity and aid in development of treatment planning.
Target Area
Accessible tooth surfaces
Review Panel
Dental
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QJX to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Caries Detection Product With Drug Or Biologic

Page Type
Product Code
Definition
Intended to aid in the detection of tooth decay by measuring increased visible light, fluorescence, or luminescence induced by caries-activated drug or biologic.
Physical State
This product is comprised of intraoral imaging system with applicator mechanism for dispensing the drug or biologic. The intraoral imaging system contains a camera and is used with compatible imaging software.
Technical Method
Product dispenses the drug or biologic onto accessible teeth in the patient’s mouth. The drug or biologic binds to caries-related constituents naturally occurring in the mouth, which induces the drug or biologic to give off increased visible light, fluorescence, or luminescence. Images of the detected visible light, fluorescence, or luminescence are used by the dental healthcare professional to see the carious lesions activity and aid in development of treatment planning.
Target Area
Accessible tooth surfaces
Review Panel
Dental
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QJX to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.